Cavernous angioma cost-effectiveness of therapy

Jump to navigation Jump to search

Cavernous angioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cavernous angioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

MRA

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous angioma cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous angioma cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous angioma cost-effectiveness of therapy

CDC on Cavernous angioma cost-effectiveness of therapy

Cavernous angioma cost-effectiveness of therapy in the news

Blogs on Cavernous angioma cost-effectiveness of therapy

Directions to Hospitals Treating Cavernous angioma

Risk calculators and risk factors for Cavernous angioma cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Since cavernous angioma can be treated via medical or surgical option, therapy for this condition is relatively cost-effective.

Cost-effectiveness of therapy


References

  1. Tripathi M, Batish A, Kumar N, Ahuja CK, Oinam AS, Kaur R; et al. (2020). "Safety and efficacy of single-fraction gamma knife radiosurgery for benign confined cavernous sinus tumors: our experience and literature review". Neurosurg Rev. 43 (1): 27–40. doi:10.1007/s10143-018-0975-8. PMID 29633079.